Intercure Ltd (INCR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Intercure Ltd Stock (INCR) Company Profile

Intercure Ltd

Healthcare (1200)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

INCR's Discussions on Twitter

Vergleichen Sie INCR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INCR Intercure Ltd	1.35	63.16M	118.18M	5.99M	-12.91M	0.1319
ZTS Zoetis Inc	176.74	80.59B	9.15B	2.43B	2.31B	4.92
HLN Haleon Plc Adr	9.72	44.17B	14.26B	1.55B	0	0.3327
TAK Takeda Pharmaceutical Co Adr	13.57	42.61B	30.27B	1.93B	3.45B	0.444
TEVA Teva Pharmaceutical Industries Ltd Adr	16.57	18.77B	16.77B	-959.00M	1.37B	-2.00
VTRS Viatris Inc	13.22	15.73B	15.05B	-883.30M	1.89B	1.53

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-05-18	Hochstufung	Canaccord Genuity	Speculative Buy → Buy

Intercure Ltd Aktie (INCR) Neueste Nachrichten

Finanzdaten der Intercure Ltd-Aktie (INCR)

Intercure Ltd (INCR)

Intercure Ltd Stock (INCR) Company Profile

Vergleichen Sie INCR mit anderen Aktien

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Intercure Ltd Aktie (INCR) Neueste Nachrichten

InterCure Ltd. (NASDAQ:INCR) Short Interest Update - MarketBeat

InterCure Ltd. (NASDAQ:INCR) Sees Significant Drop in Short Interest - MarketBeat

InterCure Ltd. (NASDAQ:INCR) Sees Large Decline in Short Interest - MarketBeat

Synbiotic's CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure - Business of Cannabis -

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive

InterCure Ltd. (NASDAQ:INCR) Sees Significant Increase in Short Interest - MarketBeat

Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany - Benzinga

InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war - Green Market Report

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewswire

InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com

InterCure partners with Cookies to launch cannabis pharmacies in Germany By Investing.com - Investing.com Australia

InterCure partners with Cookies to launch cannabis pharmacies in Germany - Investing.com

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire

InterCure (NASDAQ:INCR) Stock Price Up 0.5% - MarketBeat

Tidal Investments LLC Invests $883,000 in InterCure Ltd. (NASDAQ:INCR) - American Banking and Market News

Cannabis News: Majority of Americans Want Rescheduling or Legalization; European Market Growth Could be Game-Changer; Spotlight on InterCure - Market Research Record

Support for Regulatory Changes Surrounding Cannabis Remains Strong in the US, Companies Like InterCure Could Also Benefit From Growth in Europe - Markets Herald

Mirae Asset Global Investments Co. Ltd. Sells 467,995 Shares of InterCure Ltd. (NASDAQ:INCR) - Defense World

InterCure Ltd. (NASDAQ:INCR) Stake Cut by Mirae Asset Global Investments Co. Ltd. - MarketBeat

InterCure (NASDAQ:INCR) Shares Up 1% - MarketBeat

InterCure (NASDAQ:INCR) Trading 1% Higher - Defense World

InterCure: A Cannabis Industry Leader Still Flying Under The Radar (NASDAQ:INCR) - Seeking Alpha

InterCure (NASDAQ:INCR) Trading Down 1.2% - MarketBeat

The market capitalization of InterCure chaired by Ehud Barak is 1.000 billion shekels - Aurora Israel

IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure - Business of Cannabis -

Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ - Markets Insider

The Daily Hit: May 23, 2024 - Green Market Report

Analyst: Israel’s InterCure paving path to big gains - Green Market Report

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference - Business Wire

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - Yahoo Finance

InterCure (NASDAQ:INCR) Shares Down 4.1% - MarketBeat

InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion - Benzinga

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire

InterCure: Bargain Israel Cannabis Play (NASDAQ:INCR) - Seeking Alpha

Here's What You Missed in Cannabis, Psychedelics This WeekTipRanks.com - TipRanks

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million - Business Wire

symbol__ Stock Quote Price and Forecast - CNN

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint - Business Wire

InterCure Provides Update Regarding Nir Oz Facility in Israel - Cannabis Business Times

InterCure advances restoration of Israeli site amid conflict By Investing.com - Investing.com Canada

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain - GlobeNewswire

Israeli Cannabis Firms Navigate Challenges Amid Hamas Conflict, Cellular Goods Signs New Joint Venture, & More from SEED Innovations - Business of Cannabis -

InterCure Provides an Update Regarding the Security Situation in Israel - Financial Post

Israeli Cannabis Adjusts to War - Green Market Report

Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK - Business of Cannabis -

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY - GlobeNewswire

IM Cannabis Faces NASDAQ Delisting for Second Time Despite Stock Consolidation & Israeli Cannabis Stocks Jump ... - Business of Cannabis -

InterCure: Leader In Israel's Growing Medical Cannabis Market (NASDAQ:INCR) - Seeking Alpha

InterCure Decides to Leave Toronto Stock Exchange - Green Market Report

InterCure Ltd. Announces Proposed Voluntary Delisting from - GlobeNewswire

Finanzdaten der Intercure Ltd-Aktie (INCR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie INCR